N-(3-(4-(imidazo[1,2-b]pyridazin-3-yl)-1H-pyrazol-1-yl)-4-methylphenyl)-3-(trifluoromethyl)benzamide

ID: ALA4762806

PubChem CID: 141429631

Max Phase: Preclinical

Molecular Formula: C24H17F3N6O

Molecular Weight: 462.44

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-n1cc(-c2cnc3cccnn23)cn1

Standard InChI:  InChI=1S/C24H17F3N6O/c1-15-7-8-19(31-23(34)16-4-2-5-18(10-16)24(25,26)27)11-20(15)32-14-17(12-30-32)21-13-28-22-6-3-9-29-33(21)22/h2-14H,1H3,(H,31,34)

Standard InChI Key:  REKRJPDVODUIMJ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
    6.9034  -16.5543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9023  -17.3738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6103  -17.7828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3200  -17.3733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3172  -16.5507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6085  -16.1454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1956  -16.1458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0283  -17.7808    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.7354  -17.3711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4438  -17.7786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7341  -16.5539    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4404  -18.5942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1479  -19.0016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8560  -18.5919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8521  -17.7705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1440  -17.3668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1943  -17.7818    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4525  -17.4480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9052  -18.0549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3133  -18.7630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1127  -18.5936    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0860  -18.0484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6034  -17.3807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8222  -17.6277    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5928  -18.7063    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8170  -18.4512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2117  -18.9925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3763  -19.7918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1521  -20.0468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7632  -19.5026    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.1488  -19.8188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4416  -20.2282    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.8570  -20.2267    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.1435  -20.6320    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  4  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 10 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 10  1  0
  2 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 17  1  0
 19 22  1  0
 22 23  2  0
 23 24  1  0
 24 26  2  0
 25 22  1  0
 25 26  1  0
 25 30  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 13 31  1  0
 31 32  1  0
 31 33  1  0
 31 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4762806

    ---

Associated Targets(Human)

ABL1 Tclin Bcr/Abl fusion protein (1667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-937 (7138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK-293T (167025 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 462.44Molecular Weight (Monoisotopic): 462.1416AlogP: 5.16#Rotatable Bonds: 4
Polar Surface Area: 77.11Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 2.59CX LogP: 4.79CX LogD: 4.79
Aromatic Rings: 5Heavy Atoms: 34QED Weighted: 0.40Np Likeness Score: -2.23

References

1. Hu L,Cao T,Lv Y,Ding Y,Yang L,Zhang Q,Guo M.  (2016)  Design, synthesis, and biological activity of 4-(imidazo[1,2-b]pyridazin-3-yl)-1H-pyrazol-1-yl-phenylbenzamide derivatives as BCR-ABL kinase inhibitors.,  26  (23.0): [PMID:28029512] [10.1016/j.bmcl.2016.10.007]

Source